Lupus Erythematosus, Systemic: all 1,222 studies
Page 11 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.
- A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184CompletedNCT01953835Phase 1
- Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesStatus unknownNCT01952275
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- A Non-drug Study Profiling Cutaneous LupusCompletedNCT01923415
- Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76CompletedNCT01914770
- A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy SubjectsCompletedNCT01894360Phase 1
- Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus.CompletedNCT01892748Not applicable
- The Effect of Calcitriol on Progress and Activity of Lupus NephritisStatus unknownNCT01863641Phase 2
- Employment and Arthritis: Making it WorkActive, not recruitingNCT01852851Not applicable
- Phase Ib Study of SC Milatuzumab in SLECompletedNCT01845740Phase 1
- Effectiveness Study of Psychotherapy in Systemic Lupus ErythematosusStatus unknownNCT01840709Not applicable
- Intervention to Improve Quality of Life in African American Lupus PatientsCompletedNCT01837875Not applicable
- An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184TerminatedNCT01777256Phase 2
- Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus NephritisTerminatedNCT01773616Phase 3
- Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus ErythematosusCompletedNCT01769937Phase 4
- Safety Study of CDP7657 in Patients With Systemic Lupus ErythematosusCompletedNCT01764594Phase 1
- Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus ErythematosusStatus unknownNCT01741857Phase 1/2
- Physical Exercise, Endothelial Function and Progenitor Endothelial Cells in Systemic Lupus Erythematosus PatientsStatus unknownNCT01712529Not applicable
- A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus ErythematosusCompletedNCT01702740Phase 1
- Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLEWithdrawnNCT01702038Phase 2
- The CARRA RegistryCompletedNCT01697254
- An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)TerminatedNCT01689025Phase 1
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and GenderCompletedNCT01687309Phase 1
- Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.CompletedNCT01687192Phase 2
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT01686555Phase 1
- Safety Study of AMG 557 in Subjects With Lupus ArthritisCompletedNCT01683695Phase 1
- Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic TreatmentsStatus unknownNCT01642706
- WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)CompletedNCT01616472
- Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin LesionCompletedNCT01551069Phase 3
- Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune ThrombocytopeniaCompletedNCT01549184
- Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus NephritisTerminatedNCT01541670Phase 1
- Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) SubjectsCompletedNCT01534403Phase 2
- Belimumab (BENLYSTA®) Pregnancy RegistryCompletedNCT01532310
- CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)CompletedNCT01520155
- Japanese phase1 Study of Belimumab (IV vs SC)CompletedNCT01516450Phase 1
- Exercise and Systemic Lupus ErythematosusStatus unknownNCT01515163Not applicable
- International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus ErythematosusCompletedNCT01509989
- Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)CompletedNCT01475149
- Zostavax in Systemic Lupus ErythematosusCompletedNCT01474720Phase 1
- Ultrasound Evaluation of Hands in Patients With Systemic Lupus ErythematosusStatus unknownNCT01471301
- A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus ErythematosusTerminatedNCT01470313Phase 1
- Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE)Status unknownNCT01460680
- Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)CompletedNCT01449071Phase 1/2
- Atacicept Demonstrating Dose RESponSeWithdrawnNCT01440231Phase 2
- The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE)CompletedNCT01425775Not applicable
- Vitamin D Supplementation in Systemic Lupus ErythematosusCompletedNCT01413230
- Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus ErythematosusTerminatedNCT01407679Phase 2
- CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus ErythematosusCompletedNCT01395745Phase 3
- Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT01381536Phase 1
- The Effect of Milnacipran on Fatigue and Quality of Life in Lupus PatientsWithdrawnNCT01359826Phase 4
- Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus ErythematosusCompletedNCT01352988Phase 2
- Balancing Lupus Experiences With Stress StrategiesCompletedNCT01351662Phase 1/2
- Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on ChildrenCompletedNCT01330368
- Evaluation of the Influence of Food Regimen on Oshadi D AbsorptionCompletedNCT01327352Not applicable
- Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus ErythematosusCompletedNCT01322308Phase 4
- A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321CompletedNCT01305746Phase 2
- To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusCompletedNCT01300208Phase 2
- Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus ErythematosusCompletedNCT01294774Phase 2
- Levothyroxine in Pregnant SLE PatientsWithdrawnNCT01276782Phase 4
- Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus ErythematosusCompletedNCT01269866Not applicable
- The Role of ITGAM in Systemic Lupus ErythematosusCompletedNCT01230112
- Creatine Supplementation in Pediatric RheumatologyStatus unknownNCT01217320Not applicable
- Auto-immunity and Pulmonary Arterial HypertensionCompletedNCT01208792Not applicable
- Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol BalanceCompletedNCT01180361
- Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE)CompletedNCT01176643Not applicable
- A Trial of Rosuvastatin in Systemic Lupus ErythematosusCompletedNCT01170585Phase 2
- Safety Study of AMG 811 in Subjects With Discoid Lupus ErythematosusTerminatedNCT01164917Phase 1
- PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus ErythematosusCompletedNCT01162681Phase 2
- Catalytic Antibodies and Lupus in MartiniqueCompletedNCT01157468
- Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesStatus unknownNCT01151644Phase 4
- Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)CompletedNCT01146444Not applicable
- Reducing Depressive Symptoms in Systemic Lupus ErythematosusCompletedNCT01120652Not applicable
- Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus ManifestationsCompletedNCT01112215Phase 4
- Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE)CompletedNCT01101802Phase 4
- Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT01093911Phase 1
- Autoimmunity in Sisters of Lupus PatientsCompletedNCT01076101
- Auto-immunity in Lupus Patients After Influenza VaccineCompletedNCT01072734Phase 2
- Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus TreatmentCompletedNCT01060410
- Safety of IFNa Kinoid in Systemic Lupus ErythematosusCompletedNCT01058343Phase 1/2
- QT Dispersion in Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT01031797
- An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)WithdrawnNCT01018238Phase 1
- Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)CompletedNCT00997100Phase 2
- Physical Activity in Patients With Systemic Lupus ErythematosusStatus unknownNCT00985803Phase 1
- A Study of the Metabolic Syndrome in Patients With Systemic Lupus ErythematosusCompletedNCT00982670
- NOX-E36 First-in-Human (FIH) StudyCompletedNCT00976729Phase 1
- Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune StudyCompletedNCT00976300Phase 2
- A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus ErythematosusCompletedNCT00962832Phase 2
- An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT00960362Phase 1
- Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled StudyCompletedNCT00911521Phase 4
- Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol LevelStatus unknownNCT00866229Phase 4
- Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus ErythematosusWithdrawnNCT00858884Not applicable
- Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune DiseasesTerminatedNCT00849745Phase 1
- Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without GlomerulonephritisCompletedNCT00818948Phase 1
- Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune DiseaseCompletedNCT00815282Phase 4
- The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus ErythematosusStatus unknownNCT00797784Phase 2
- Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteineActive, not recruitingNCT00775476Phase 2
- A Study of AMG 557 in Adults With Systemic Lupus ErythematosusCompletedNCT00774943Phase 1
- Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus ErythematosusWithdrawnNCT00752999Phase 2
- Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)Status unknownNCT00750971Phase 2
- Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in TaiwanStatus unknownNCT00747578